Results 81 to 90 of about 28,789 (229)

Central retinal vein and artery occlusion associated with sildenafil: a case report and review of the literature

Journal of Medical Case Reports, 2023
Background Sildenafil is a selective phosphodiesterase type 5 inhibitor used for the treatment of erectile dysfunction and pulmonary hypertension. It is available over the counter in many countries. While there have been a few reports of retinal vascular
Ali Torkashvand, Pasha Anvari, Siavash Ketabi, Esmaeil Asadi Khameneh   +3 more
doaj   +1 more source

Stromal Cell-Derived Factor 1 Polymorphism in Retinal Vein Occlusion [PDF]

, 2016
BACKGROUND: Stromal cell-derived factor 1 (SDF1) has crucial role in the regulation of angiogenesis and ocular neovascularisation (NV). The purpose of this study was to evaluate the association between SDF1-3'G(801)A polymorphism and NV complications of ...
A Aiuti, A Ide, AM Abu El-Asrar, AM Joussen, Andrea Fekete, Andrea Szigeti, AO Sahin, AR Cardones, B Luan, Balázs Lesch, D Dubois-Laforgue, DJ Browning, FC Lam, Graham R. Wallace, J Kijowski, JG Santiago, JM Butler, JS Shilling, K Sonmez, Lilla Lénárt, LY Chen, M Burger, Miklós Schneider, Mónika Ecsedy, R Colobran, R Lima e Silva, R Salcedo, RL Funderburk, RL McIntosh, S Raffi, S Rogers, SL Rogers, SS Hayreh, SS Hayreh, SS Hayreh, T Warchol, TJ Glass, XL Gu, Y Ki-I, Z Djuric, Zoltán Zsolt Nagy, Zsuzsanna Récsán   +41 more
core   +4 more sources

Patient‐reported outcomes and visual function after four refractive strategies in cataract surgery: A randomized controlled trial

Acta Ophthalmologica, EarlyView.
Abstract Purpose To evaluate patient‐reported outcome measures (PROMs) and visual function across four groups of public cataract patients: emmetropia, mini‐monovision, monovision with partial‐range of field (RoF) narrow intraocular lenses (IOLs) and patients implanted with partial‐RoF extended IOLs.
Anne Guldhammer Skov, Morten la Cour, Birgitte Moldow, Lars Holm, Therese Krarup   +4 more
wiley   +1 more source

Sequential occlusion of the branch retinal artery and branch retinal vein in a patient with hypertension: an interventional case report

Clinical Ophthalmology, 2014
Norio Okamoto, Chota Matsumoto, Yoshikazu Shimomura Department of Ophthalmology, Kinki University Faculty of Medicine, Osakasayama City, Osaka, Japan Background: There are some cases that reported central retinal vein occlusion accompanied by ciliary ...
Okamoto N, Matsumoto C, Shimomura Y
doaj  

Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion [PDF]

, 2005
Background Many available data have suggested that hyperhomocysteinaemia, an established independent risk factor for thrombosis (arterial and venous), may be associated with an increased risk of retinal vein occlusion (RVO).
Paola Terrazzi, Pierpaolo Di Micco, Ilaria Quaglia, Lisa Rossi, Alessandro Bellatorre, Giorgio Gaspari, Lidia Rota, Corrado Lodigiani   +7 more
core   +2 more sources

Central retinal vein occlusion: a review [PDF]

Clinical & Experimental Ophthalmology, 2011
AbstractCentral retinal vein occlusion remains a common cause of unilateral visual loss. Until recently, our treatment options for this condition were limited only to laser photocoagulation for the devastating end sequelae of anterior segment neovascularization.
openaire   +2 more sources

Exploring market dynamics of biological including biosimilar treatments for retinal diseases in Europe: An interrupted time‐series analysis

Acta Ophthalmologica, EarlyView.
Abstract Purpose To assess the impact of biosimilar ranibizumab and on‐patent faricimab market entry on pricing and utilization trends and describe national variation in off‐label bevacizumab use in Europe. Methods Interrupted time series analysis of quarterly sales data (Q1 2018–Q2 2024) in 11 European countries evaluated ranibizumab utilization and ...
Elif Car, Isabelle Huys, Steven Simoens, Arnold G. Vulto   +3 more
wiley   +1 more source

Intravitreal injection of Ozurdex(®) implant in patients with persistent diabetic macular edema, with six-month follow-up [PDF]

, 2016
AIM: To evaluate the efficacy of intravitreal dexamethasone injections in diabetic macular edema (DME). METHODS: A 700 μg slow-release intravitreal dexamethasone implant (Ozurdex®) was placed in the vitreal cavity of 17 patients (19 eyes) affected ...
Bottone, A, FAMELI, VALERIA, Ferraresi, AF, Giustolisi, R, Lenzi, T, PACELLA, Elena, Pacella, F, Romano, MR, Turchetti, P   +8 more
core   +2 more sources

Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab [PDF]

, 2018
Background: Predicting how patients with central retinal vein occlusion (CRVO) will respond to intravitreal anti-VEGF is challenging. The purpose of this study was to identify pre-treatment clinical features in CRVO that predict visual acuity (VA ...
Brogan, Kerr, Gilmour, David Francis, Precup, Monica, Rodger, Amanda, Young, David   +4 more
core   +1 more source

Central retinal vein occlusion and thrombophilia [PDF]

Eye, 2002
Central retinal vein occlusion is one of the commonest vascular diseases of the eye. The pathogenesis is multifactorial with both local factors and systemic diseases being aetiologically important. Many thrombophilic conditions have recently been identified and studies looking at their potential role in CRVO have been undertaken. The aim of this review
openaire   +2 more sources